Application of concordance probability estimate to predict conversion from mild cognitive impairment to Alzheimer's disease
暂无分享,去创建一个
[1] M A Pericak-Vance,et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.
[2] Sterling C. Johnson,et al. A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease , 2016, Scientific Reports.
[3] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[4] Y. Shao,et al. On comparing 2 correlated C indices with censored survival data , 2017, Statistics in medicine.
[5] Zhezhen Jin,et al. Comparing paired biomarkers in predicting quantitative health outcome subject to random censoring , 2016, Statistical methods in medical research.
[6] N. Fogelson,et al. Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using MRI and Structural Network Features , 2016, Front. Aging Neurosci..
[7] P. S. St George-Hyslop,et al. Prediction of probable Alzheimer's disease in memory-impaired patients , 1996, Neurology.
[8] C. Jack,et al. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance , 2012, Neurobiology of Aging.
[9] Yilong Zhang,et al. Concordance measure and discriminatory accuracy in transformation cure models. , 2018, Biostatistics.
[10] Catharina Lange,et al. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion. , 2015, Journal of Alzheimer's disease : JAD.
[11] Georg Kemmler,et al. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine , 2008, Neurobiology of Aging.
[12] Sudha Seshadri,et al. Development and validation of a brief dementia screening indicator for primary care , 2014, Alzheimer's & Dementia.
[13] Nicolas Cherbuin,et al. A Self-Report Risk Index to Predict Occurrence of Dementia in Three Independent Cohorts of Older Adults: The ANU-ADRI , 2014, PloS one.
[14] Dong Han,et al. Diagnostic accuracy of 18F‐FDG and 11C‐PIB‐PET for prediction of short‐term conversion to Alzheimer’s disease in subjects with mild cognitive impairment , 2012, International journal of clinical practice.
[15] A. Barczak,et al. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging. , 2015, Neurologia i neurochirurgia polska.
[16] M. Gonen,et al. Concordance probability and discriminatory power in proportional hazards regression , 2005 .
[17] Daniel Rueckert,et al. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease , 2017, IEEE Transactions on Biomedical Engineering.
[18] F. Harrell,et al. Regression modelling strategies for improved prognostic prediction. , 1984, Statistics in medicine.
[19] Geert Jan Biessels,et al. Midlife risk score for the prediction of dementia four decades later , 2014, Alzheimer's & Dementia.
[20] M. Pencina,et al. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.
[21] M. Tsolaki,et al. Prediction of conversion from mild cognitive impairment to Alzheimer's disease by CSF cytochrome c levels and N200 latency. , 2009, Current Alzheimer research.
[22] H. Zou. The Adaptive Lasso and Its Oracle Properties , 2006 .
[23] M. Pencina,et al. On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data , 2011, Statistics in medicine.
[24] F. Jessen,et al. The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment. , 2015, Journal of Alzheimer's disease : JAD.
[25] Huaxi Xu,et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.
[26] J. Weuve,et al. 2016 Alzheimer's disease facts and figures , 2016 .
[27] Hilkka Soininen,et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study , 2006, The Lancet Neurology.
[28] J. Price,et al. Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.
[29] A. Simmons,et al. Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion , 2011, Alzheimer's & Dementia.
[30] Hilkka Soininen,et al. Prevalence of mild cognitive impairment: A population-based study in elderly subjects , 2000, Neurobiology of Aging.
[31] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .